These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5116171)

  • 21. [Mucocutaneous lesions produced by Leishmania Braziliensis].
    Lasala Carreras A
    Acta Odontol Venez; 1974 Apr; 12(1):3-21. PubMed ID: 4535200
    [No Abstract]   [Full Text] [Related]  

  • 22. [American cutaneous and mucous leishmaniasis (mucocutaneous leishmaniasis)].
    Lieske H
    Hautarzt; 1979 Nov; 30(11):604-6. PubMed ID: 521290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of mucocutaneous leishmaniasis.
    Virgilio GR; Hale BR
    Otolaryngol Head Neck Surg; 2005 May; 132(5):800-1. PubMed ID: 15886638
    [No Abstract]   [Full Text] [Related]  

  • 24. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
    Nonata R; Sampaio R; Marsden PD
    Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
    [No Abstract]   [Full Text] [Related]  

  • 25. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
    Rocha RA; Sampaio RN; Guerra M; Magalhâes A; Cuba CC; Barreto AC; Marsden PD
    J Trop Med Hyg; 1980 Aug; 83(4):131-9. PubMed ID: 6997505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucocutaneous leishmaniasis: mucosal manifestations in an endemic country.
    de Paulo LF; Rocha GF; Luisi CM; Rosa RR; Durighetto AF
    Int J Infect Dis; 2013 Nov; 17(11):e1088-9. PubMed ID: 23867693
    [No Abstract]   [Full Text] [Related]  

  • 27. Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review.
    Mosimann V; Neumayr A; Paris DH; Blum J
    Acta Trop; 2018 Jun; 182():246-250. PubMed ID: 29550282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems of drug evaluation in cutaneous leishmaniasis.
    Ercoli N; Coelho MV
    Ann Trop Med Parasitol; 1967 Dec; 61(4):488-9. PubMed ID: 5634139
    [No Abstract]   [Full Text] [Related]  

  • 29. Mucocutaneous leishmaniasis--an unsolved clinical problem.
    Marsden PD; Sampaio RN; Rocha R; Radke M
    Trop Doct; 1977 Jan; 7(1):7-11. PubMed ID: 841692
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of tegumental leishmaniasis].
    Azulay RD
    Hospital (Rio J); 1966 Nov; 70(5):1231-41. PubMed ID: 5301941
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucocutaneous leishmaniasis complicating systemic lupus erythematosus and responding to high dose amphotericin B.
    Matos AL; Figueiredo C; Alves F; Pereira N; Gonçalo M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e756-e758. PubMed ID: 34057771
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM; Lumbreras C; González-Vidal D;
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short communication: mucocutaneous leishmaniasis in HIV-related immune reconstitution syndrome.
    Lee GL; Woods KL; Clark L; Peters S; Wong HK; McGwire BS
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):889-92. PubMed ID: 26154873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: Mucocutaneous Leishmaniasis Masquerading as Idiopathic Midline Granulomatous Disease.
    Tejura N; Kim E; Dever LL; Chew D
    Am J Trop Med Hyg; 2019 Nov; 101(5):1107-1110. PubMed ID: 31549620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India.
    Jha TK; Giri YN; Singh TK; Jha S
    Am J Trop Med Hyg; 1995 Jun; 52(6):536-8. PubMed ID: 7611561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological risk factors for amphotericin B nephrotoxicity in children.
    Goldman RD; Ong M; Wolpin J; Doyle J; Parshuram C; Koren G
    J Clin Pharmacol; 2007 Aug; 47(8):1049-54. PubMed ID: 17525169
    [No Abstract]   [Full Text] [Related]  

  • 38. Apparent cure of a difficult treatment problem in a patient with mucosal leishmaniasis.
    Marsden PD; Netto EM; Badaró R; Cuba CA; Costa JL; Barreto AC
    Am J Trop Med Hyg; 1986 Mar; 35(2):449. PubMed ID: 3006531
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
    Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
    Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
    [No Abstract]   [Full Text] [Related]  

  • 40. Leishmaniasis of the tongue in a renal transplant recipient.
    Alrajhi AA; Saleem M; Ibrahim EA; Gramiccia M
    Clin Infect Dis; 1998 Nov; 27(5):1332-3. PubMed ID: 9827301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.